TP53 and Esophageal atresia: Analysis of genetic progression of BE has identified abnormalities in the tumor-suppressor genes TP53 and CDKN2A, as well as DNA content abnormalities (tetraploidy and aneuploidy) as critical events in the evolution of EA [28–40].